Previous 10 | Next 10 |
Late-breaking presentation shows durable results, including high freedom from major amputation Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral...
Company introduces Diamondback 360° Exchangeable Series to treat multi-level PAD Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coro...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at...
Cardiovascular Systems, Inc. (CSII) Q2 2019 Earnings Conference Call August 06, 2019, 16:30 ET Company Participants John Nielsen - VP, IR & Corporate Communications Scott Ward - Chairman, President & CEO Jeffrey Points - CFO Rhonda Robb - COO Ryan Egeland - VP, Medica...
Cardiovascular Systems (NASDAQ: CSII ): Q4 GAAP EPS of $0.04 in-line. More news on: Cardiovascular Systems, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Conference Call Scheduled for Today, August 6, 2019, at 3:30 PM CT (4:30 PM ET) R evenues of $68.2 million increased 15.4% from fourth quarter last year Net income was $1.5 million, or $0.04 per basic and diluted share Company introduces fiscal 2020 financial guidance ...
CSI to Commercialize Product upon Successful Manufacturing Transfer Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery diseas...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Erik Paulsen. He ...
Aurora Cannabis (NYSE: ACB ) initiated with Buy rating and $9 (26% upside) price target at Ladenburg Thalmann. More news on: Aurora Cannabis Inc., Acreage Holdings, Inc., Tilray, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...